HCP (HCP) : The most positive equity analysts on HCP (HCP) expects the shares to touch $43, whereas, the least positive believes that the stock will trade at $32 in the short term. The company is covered by 7 Wall Street Brokerage Firms. The average price target for shares are $35.43 with an expected fluctuation of $4.12 from the mean.
HCP (HCP) : Zacks Investment Research ranks HCP (HCP) as 2, which is a Buy recommendation. 1 other analysts are mildly bullish on the stock and favor a Buy. Not everyone is convinced about the stocks future, hence, the stock receives 1 Sell recommendation. 3 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 5 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 10 research analysts is 3.53, which indicates as a Sell.
Also, BTIG Research initiates coverage on HCP (NYSE:HCP) The current rating of the shares is Neutral. The rating by the firm was issued on August 25, 2016.
HCP (NYSE:HCP): The stock opened at $39.35 on Thursday but the bulls could not build on the opening and the stock topped out at $39.39 for the day. The stock traded down to $38.59 during the day, due to lack of any buying support eventually closed down at $38.80 with a loss of -1.35% for the day. The stock had closed at $39.33 on the previous day. The total traded volume was 2,668,167 shares.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.